Related Experiment Video

Updated: Dec 20, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.3K

Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room

Roberto Assandri1, Elisabetta Buscarini2, Ciro Canetta3

  • 1Clinical Investigation Laboratory, Ospedale Maggiore di Crema, Crema, Italy.

Archives of Medical Research
|May 31, 2020
PubMed

Insights

The novel Coronavirus pandemic necessitates timely diagnosis. Key parameters like Lymphocyte count, SaO2, and CRP serum levels can help assess COVID-19 severity in emergency settings.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Clinical Diagnostics

Background:

  • The World Health Organization declared the novel Coronavirus (COVID-19) a global pandemic, creating a significant public health crisis.
  • Timely laboratory diagnostics are crucial for managing the COVID-19 pandemic.
  • Identifying accessible biomarkers for assessing disease severity is essential for effective emergency room triage.

Purpose of the Study:

  • To evaluate the utility of specific laboratory parameters in assessing COVID-19 severity.
  • To determine if Lymphocyte count, SaO2, and C-reactive protein (CRP) serum levels can serve as indicators of disease severity in emergency settings.

Main Methods:

  • Retrospective analysis of patient data.
  • Measurement of Lymphocyte count, SaO2, and CRP serum levels in emergency room patients diagnosed with COVID-19.

Main Results:

  • Lymphocyte count, SaO2, and CRP serum levels were identified as potential indicators for assessing COVID-19 severity.
  • These parameters provide valuable information for risk stratification in emergency care.

Conclusions:

  • Lymphocyte count, SaO2, and CRP serum levels are practical parameters for evaluating COVID-19 severity in emergency departments.
  • These biomarkers can aid clinicians in making informed decisions for patient management during the pandemic.

Keywords:
Covid-19Laboratory testRT-PCR

More Related Videos

Remote Laboratory Management: Respiratory Virus Diagnostics14:56

Remote Laboratory Management: Respiratory Virus Diagnostics

Published on: April 6, 2019

33.5K
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.6K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
689
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
434
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
142
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
696